Because immune infiltration inside tumour tissues indicates an adequate anti-tumour immune response, high TLR7 and TLR8 expression may predict a better patient prognosis, providing support for a wide range of immune therapies targeting TLR7 and TLR8 [58–61]. This evidence concerns the gene TLR7 and neoplasm.